Evaluating the process of standardizing investigational drug substance names reported to the United States Food and Drug Administration adverse event reporting system

被引:0
|
作者
Fung, Maggie [1 ]
Brajovic, Sonja [1 ]
Patel, Nitin [1 ]
Chang, Sherry [1 ]
机构
[1] US FDA, Silver Spring, MD USA
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
383
引用
收藏
页码:189 / 190
页数:2
相关论文
共 50 条
  • [21] Analysis of adverse events with sclerosants reported to the United States Food and Drug Administration
    Nguyen, Christopher N.
    Nguyen, Quoc-Bao D.
    Silapunt, Sirunya
    PHLEBOLOGY, 2022, 37 (06) : 452 - 459
  • [22] Analysis of adverse events with sclerosants reported to the United States Food and Drug Administration
    Nguyen, Christopher
    Quoc-Bao Nguyen
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB17 - AB17
  • [23] Cardiovascular Toxicities of Ibrutinib: A Pharmacovigilance Study Based on the United States Food and Drug Administration Adverse Event Reporting System Database
    Zheng, Yi
    Guo, Xiaojing
    Chen, Chenxin
    Chi, Lijie
    Guo, Zhijian
    Liang, Jizhou
    Wei, Lianhui
    Chen, Xiao
    Ye, Xiaofei
    He, Jia
    PHARMACEUTICALS, 2023, 16 (01)
  • [24] Assessment of pancreatitis associated with tocilizumab use using the United States Food and Drug Administration Adverse Event Reporting System database
    Ashwin Kamath
    Sahana D. Acharya
    Rashmi R. Rao
    Sheetal D. Ullal
    Scientific Reports, 11
  • [25] Assessment of pancreatitis associated with tocilizumab use using the United States Food and Drug Administration Adverse Event Reporting System database
    Kamath, Ashwin
    Acharya, Sahana D.
    Rao, Rashmi R.
    Ullal, Sheetal D.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [26] Evaluating drug withdrawal syndrome risks through food and drug administration adverse event reporting system: a comprehensive disproportionality analysis
    Zhang, Zheng
    Yang, Qianzhi
    Chen, Minghao
    Yang, Wah
    Wang, Yuping
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [27] Trends in copper versus hormonal intrauterine device breakage reporting within the United States? Food and Drug Administration Adverse Event Reporting System
    Latack, Kyle R.
    Nguyen, Brian T.
    CONTRACEPTION, 2023, 118
  • [28] Exploratory disproportionality analysis of potentially drug-induced eosinophilic pneumonia using United States Food and Drug Administration adverse event reporting system
    Kamath, Ashwin
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [29] US Food and Drug Administration Safety Advisories and Reporting to the Adverse Event Reporting System (FAERS)
    Thomas J. Moore
    Richard L. Morrow
    Colin R. Dormuth
    Barbara Mintzes
    Pharmaceutical Medicine, 2020, 34 : 135 - 140
  • [30] US Food and Drug Administration Safety Advisories and Reporting to the Adverse Event Reporting System (FAERS)
    Moore, Thomas J.
    Morrow, Richard L.
    Dormuth, Colin R.
    Mintzes, Barbara
    PHARMACEUTICAL MEDICINE, 2020, 34 (02) : 135 - 140